Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 8, 2021
Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial InvestigatorsRaymond S Douglas, Yao Wang, Roger A Dailey, et al.Clinical Lymphoma, Myeloma & Leukemia|March 13, 2017
Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT HistologiesBinod Dhakal, Timothy S Fenske, Sridevi Ramalingam, et al.Ophthalmic Plastic and Reconstructive Surgery|June 6, 2023
Inflammation and Fibrosis in Orbital Inflammatory Disease: A Histopathologic AnalysisRohan Verma, Allison J Chen, Dongseok Choi, et al.The New England Journal of Medicine|May 4, 2017
Teprotumumab for Thyroid-Associated OphthalmopathyTerry J Smith, George J Kahaly, Daniel G Ezra, et al.Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.The British Journal of Ophthalmology|February 27, 2021
Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesisRohan Verma, Dongseok Choi, Allison J Chen, et al.The British Journal of Ophthalmology|June 4, 2015
Fibrosis, gene expression and orbital inflammatory diseaseJames T Rosenbaum, Dongseok Choi, David J Wilson, et al.JAMA Ophthalmology|April 17, 2015
Parallel Gene Expression Changes in Sarcoidosis Involving the Lacrimal Gland, Orbital Tissue, or BloodJames T Rosenbaum, Dongseok Choi, David J Wilson, et al.Plos One|October 11, 2014
IgG4 immunostaining and its implications in orbital inflammatory diseaseAmanda J Wong, Stephen R Planck, Dongseok Choi, et al.Pageof 7